| Rachel B Cook, MD | |
|
605 Medical Ct Ste 203, Brenham, TX 77833-5406 | |
| (979) 830-1444 | |
| (979) 830-1866 |
| Full Name | Rachel B Cook |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 13 Years |
| Location | 605 Medical Ct Ste 203, Brenham, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043506439 | NPI | - | NPPES |
| 346575901 | Medicaid | TX | |
| 346575902 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | Q3167 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bellville St Joseph Health Center | Bellville, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Berkeley Eye Institute, Pllc | 4082602156 | 61 |
News Archive
A subset of immune cells directly target colon cancers, rather than the immune system, giving the cells the aggressive properties of cancer stem cells.
An international study reveals that infective endocarditis, infection and inflammation involving the heart valves is commonly associated with health care factors and is increasingly due to staphylococcal infection, according to a study in the June 22/29 issue of JAMA.
MGB Biopharma, a biopharmaceutical company developing a truly novel class of anti-infectives, to address the major global problem of antibiotic resistance today announces that the first group of healthy male volunteers have been dosed in a Phase I clinical trial assessing the safety and tolerability of an oral formulation of MGB-BP-3, for use in the treatment of Clostridium difficile infections.
Nordion Inc., a leading provider of products and services to the global health science market, today announced it has signed a five-year contract with Sterigenics International, a global leader in contract sterilization and ionization services, for the supply of Cobalt-60. Under the terms of the agreement, this contract extends until October 31, 2015.
› Verified 2 days ago
| Entity Name | Berkeley Eye Institute, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740286186 PECOS PAC ID: 4082602156 Enrollment ID: O20040505001572 |
News Archive
A subset of immune cells directly target colon cancers, rather than the immune system, giving the cells the aggressive properties of cancer stem cells.
An international study reveals that infective endocarditis, infection and inflammation involving the heart valves is commonly associated with health care factors and is increasingly due to staphylococcal infection, according to a study in the June 22/29 issue of JAMA.
MGB Biopharma, a biopharmaceutical company developing a truly novel class of anti-infectives, to address the major global problem of antibiotic resistance today announces that the first group of healthy male volunteers have been dosed in a Phase I clinical trial assessing the safety and tolerability of an oral formulation of MGB-BP-3, for use in the treatment of Clostridium difficile infections.
Nordion Inc., a leading provider of products and services to the global health science market, today announced it has signed a five-year contract with Sterigenics International, a global leader in contract sterilization and ionization services, for the supply of Cobalt-60. Under the terms of the agreement, this contract extends until October 31, 2015.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rachel B Cook, MD 605 Medical Ct Ste 203, Brenham, TX 77833-5406 Ph: (979) 830-1444 | Rachel B Cook, MD 605 Medical Ct Ste 203, Brenham, TX 77833-5406 Ph: (979) 830-1444 |
News Archive
A subset of immune cells directly target colon cancers, rather than the immune system, giving the cells the aggressive properties of cancer stem cells.
An international study reveals that infective endocarditis, infection and inflammation involving the heart valves is commonly associated with health care factors and is increasingly due to staphylococcal infection, according to a study in the June 22/29 issue of JAMA.
MGB Biopharma, a biopharmaceutical company developing a truly novel class of anti-infectives, to address the major global problem of antibiotic resistance today announces that the first group of healthy male volunteers have been dosed in a Phase I clinical trial assessing the safety and tolerability of an oral formulation of MGB-BP-3, for use in the treatment of Clostridium difficile infections.
Nordion Inc., a leading provider of products and services to the global health science market, today announced it has signed a five-year contract with Sterigenics International, a global leader in contract sterilization and ionization services, for the supply of Cobalt-60. Under the terms of the agreement, this contract extends until October 31, 2015.
› Verified 2 days ago
Dr. Peter G Amaral, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 635 Medical Pkwy, Brenham, TX 77833 Phone: 979-830-1444 Fax: 979-830-1866 | |
Steven Alexander Beim, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1205 S Austin St, Brenham, TX 77833 Phone: 979-251-9990 Fax: 979-251-7003 | |
Cheryl Joan Horton, MD Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 1102 Hwy 290w, Brenham, TX 77833 Phone: 979-836-9811 Fax: 979-836-1212 |